Odyssey Therapeutics
Cambridge, MA, United States
Senior Director of Biology at Odyssey Therapeutics
0061: Discovery of a RIPK2 Scaffolding Inhibitor for the Treatment of Joint Autoimmune Diseases
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure information not submitted.